Chris Karazin spent three years running Carolindica without taking a paycheck. He started the Raleigh hemp business in 2019 with his brother and a friend, mixing CBD products in a kitchen while covering his bills with other work. Seven years later, the company has multiple stores, its own manufacturing operation and dozens of employees. Now a federal rule change set to take effect December 11 has him reconsidering what the business can even sell.
A new federal threshold reshapes what counts as legal hemp
Congress folded the restriction into the One Big Beautiful Bill Act, the 2025 tax and spending package. Starting December 11, hemp products will need to contain no more than 0.4 milligrams of THC per consumer container to remain federally legal. That's a sharp departure from the framework established under the 2018 Farm Bill, which measured compliance by dry-weight percentage rather than milligrams per container - a distinction that allowed a wide range of gummies, drinks, tinctures and even some CBD products to reach store shelves legally. The new per-container cap is tight enough that it could sweep in products nobody would consider intoxicating, since even trace THC naturally present in full-spectrum CBD can push a package over the line. A separate provision, taking effect November 12, removes synthetic cannabinoids and compounds hemp plants can't naturally produce from the federal definition of hemp, reclassifying them as marijuana under federal law.
For retailers, this isn't a labeling tweak. It's a compliance cliff. Inventory that passed lab testing and carried a valid certificate of analysis under the old rules may simply become unsellable under the new one, regardless of how it was marketed or who it was sold to.
Operators face a narrow window to adapt inventory and sourcing
Karazin said Carolindica is looking at supplements and functional mushroom products as potential replacements for THC-based lines. That kind of pivot takes capital, shelf space planning and new supplier relationships - not something a single-location shop can turn around in weeks. "Most companies are retail, distribution and e-commerce," he said. "Those types of companies have no way of adapting at all."That gap matters for the broader market. North Carolina's hemp industry has grown into a roughly $3 billion sector employing about 16,000 people, built largely on the regulatory space Congress opened in 2018. A report from Raleigh Dispensaries, which tracks hemp retailers across seven Triangle-area counties, found that 79 of 82 shops it surveyed carried at least one product category likely to be affected by the new limit. Jake St. Peter, who runs the database, estimated more than 90 percent of shops in the region could feel some impact. Bloom Collective in Raleigh has already announced it's closing, citing pressure from the incoming rules.
The ripple effects extend past the storefront. Farmers who grow hemp for cannabinoid extraction could lose buyers if manufacturers scale back production runs. Wholesalers and brands built around THC-infused beverages or gummies will need new compliant formulations or new markets entirely - not a simple SKU swap when the underlying chemistry of the product is the problem.
State lawmakers remain divided on how to respond
North Carolina's legislature has its own parallel fight brewing. The state Senate passed a bill last summer mirroring the federal THC cap and adding a 21-and-older purchase requirement for hemp consumables, including CBD. The House declined to take it up in August, with Speaker Destin Hall saying lawmakers needed more time and might revisit the issue after the November elections. Meanwhile, Gov. Josh Stein's Advisory Council on Cannabis is working in the opposite direction, drafting recommendations for a regulated adult-use cannabis market, with a final report due to the governor by year's end. An Elon University poll found 75 percent of North Carolina adults support medical cannabis legalization and 55 percent support recreational legalization - numbers that suggest public appetite for regulation rather than elimination.
Karazin said he'd welcome rules on age verification, child-resistant packaging and standardized lab testing. What worries him is a different outcome: a federal and state one-two punch that closes the legal market altogether rather than building the oversight framework operators like him say the industry actually needs. "Regulation is what we need," he said. "Prohibition is just hilarious regression."
